Literature DB >> 29353073

Serum HBV DNA plus RNA shows superiority in reflecting the activity of intrahepatic cccDNA in treatment-naïve HBV-infected individuals.

Hongxin Huang1, Jie Wang2, Weijie Li3, Ran Chen2, Xiangmei Chen2, Fengmin Zhang4, Dongping Xu5, Fengmin Lu6.   

Abstract

BACKGROUND: Both serum hepatitis B virus (HBV) DNA and RNA can reflect intrahepatic covalently closed circular DNA (cccDNA) activity. However, correlations among viral markers haven't been fully explored.
OBJECTIVES: Here we investigated the correlations between serum HBV RNA and other viral markers in acute hepatitis B patients and treatment-naïve chronic HBV-infected individuals. STUDY
DESIGN: The serum viral markers of 19 acute hepatitis B patients and 84 treatment-naïve chronic HBV-infected individuals at different infection stages were quantified. Correlations among viral markers were analyzed by Pearson's or Spearman's correlation analysis.
RESULTS: Serum viral markers and intrahepatic cccDNA levels were lower in acute hepatitis B patients than in treatment-naïve chronic HBV-infected individuals. Serum HBV RNA levels were positively correlated with serum HBV DNA, HBsAg and intrahepatic cccDNA levels in HBeAg-positive chronic HBV-infected individuals. Total serum HBV nucleic acids (HBV DNA plus RNA) showed superiority in reflecting intrahepatic cccDNA activity. Stratified analysis revealed that such correlations were only found in HBeAg-positive chronic hepatitis B phase. Moreover, high-frequency R193M and P196A mutations were found in the RT region of HBV polymerase leading to lower serum HBV DNA and higher serum HBV RNA levels in HBeAg-negative chronic HBV infection phase.
CONCLUSIONS: HBV replication capability was lower in acute hepatitis B patients than in chronic HBV-infected individuals. In treatment-naïve HBeAg-positive chronic HBV-infected individuals, serum HBV DNA plus RNA showed superiority in reflecting intrahepatic cccDNA activity than each alone. Moreover, mutated RT region of HBV polymerase might lead to the attenuated reverse transcriptional activity of HBV polymerase in HBeAg-negative chronic HBV infection phase.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Covalently closed circular DNA; Hepatitis B e antigen; Hepatitis B surface antigen; Hepatitis B virus; Pregenomic RNA

Mesh:

Substances:

Year:  2018        PMID: 29353073     DOI: 10.1016/j.jcv.2017.12.016

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  26 in total

1.  Diagnostic Value of Detection of Pregenomic RNA in Sera of Hepatitis B Virus-Infected Patients with Different Clinical Outcomes.

Authors:  Ni Lin; Aizhu Ye; Jinpiao Lin; Can Liu; Jinlan Huang; Ya Fu; Songhang Wu; Siyi Xu; Long Wang; Qishui Ou
Journal:  J Clin Microbiol       Date:  2020-01-28       Impact factor: 5.948

2.  [Predictive value of serum HBV RNA for therapeutic effect of entecavir in patients with chronic hepatitis B].

Authors:  Y Zhu; Y Luo; F Guo; K Yang; H Fan; C Liu; B Huang; X Tang; Y Guan
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-08-20

3.  Correlation of HBcrAg with Intrahepatic Hepatitis B Virus Total DNA and Covalently Closed Circular DNA in HBeAg-Positive Chronic Hepatitis B Patients.

Authors:  Lin Wang; Xi Cao; Zhenzi Wang; Yuhua Gao; Juan Deng; Xueen Liu; Hui Zhuang
Journal:  J Clin Microbiol       Date:  2019-01-02       Impact factor: 5.948

Review 4.  Serum Hepatitis B Virus RNA: A New Potential Biomarker for Chronic Hepatitis B Virus Infection.

Authors:  Shi Liu; Bin Zhou; Juan D Valdes; Jian Sun; Haitao Guo
Journal:  Hepatology       Date:  2019-03-20       Impact factor: 17.425

Review 5.  An Overview of Hepatitis B Virus Surface Antigen Secretion Inhibitors.

Authors:  Alireza Mohebbi; Nazanin Lorestani; Alireza Tahamtan; Niki L Kargar; Alijan Tabarraei
Journal:  Front Microbiol       Date:  2018-04-05       Impact factor: 5.640

6.  Serum Hepatitis B Virus RNA Levels Predict HBeAg Seroconversion and Virological Response in Chronic Hepatitis B Patients with High Viral Load Treated with Nucleos(t)ide Analog.

Authors:  Xin Ji; Muye Xia; Bin Zhou; Shi Liu; GuiChan Liao; Shaohang Cai; Xiaoyong Zhang; Jie Peng
Journal:  Infect Drug Resist       Date:  2020-06-22       Impact factor: 4.003

Review 7.  Viral Biomarkers in Chronic HBeAg Negative HBV Infection.

Authors:  Emilia Hadziyannis; Andreas Laras
Journal:  Genes (Basel)       Date:  2018-09-27       Impact factor: 4.096

8.  Clinical Implications of Serum Hepatitis B Virus Pregenomic RNA Kinetics in Chronic Hepatitis B Patients Receiving Antiviral Treatment and Those Achieving HBsAg Loss.

Authors:  I-Chin Wu; Wen-Chun Liu; Yen-Cheng Chiu; Hung-Chih Chiu; Pin-Nan Cheng; Ting-Tsung Chang
Journal:  Microorganisms       Date:  2021-05-26

9.  Serum HBV RNA is a Potential Predictor of Hepatitis B Surface Antigen Reversion.

Authors:  Jie Wang; Xiangmei Chen; Yali Wu; Zhenhuan Cao; Leijie Wang; Hongxin Huang; Xinyue Chen; Fengmin Lu
Journal:  Hepatol Commun       Date:  2018-09-24

10.  Disease burden of chronic hepatitis B and complications in China from 2006 to 2050: an individual-based modeling study.

Authors:  Yang Zheng; Jie Wu; Cheng Ding; Kaijin Xu; Shigui Yang; Lanjuan Li
Journal:  Virol J       Date:  2020-08-28       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.